Advanced Search

Project: Treatment for Bipolar Disorder [entered retrospectively]

Public Report Complete



Project Summary

Title and Description


Key Questions


Associated Extraction Forms

Title Created by Key Questions Addressed Form Notes
Treatment for Bipolar Disorder Victoria Nelson 1, 2, 3, 4


Associated Studies (each link opens a new tab)

Title Author Year
Effectiveness of individual psychoeducation on recurrence in bipolar disorder; a controlled study. Gumus F., Buzlu S., Cakir S. 2015
Psychoeducation and online mood tracking for patients with bipolar disorder: A randomised controlled trial. Bilderbeck AC., Atkinson LZ., McMahon HC., Voysey M., Simon J., Price J., Rendell J., Hinds C., Geddes JR., Holmes E., Miklowitz DJ., Goodwin GM. 2016
A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression. Fitzgerald PB., Hoy KE., Elliot D., McQueen S., Wambeek LE., Daskalakis ZJ. 2016
The long-term outcomes of an effectiveness trial of group versus individual psychoeducation for bipolar disorders. Kallestad H., Wullum E., Scott J., Stiles TC., Morken G. 2016
Clinical effectiveness and acceptability of structured group psychoeducation versus optimised unstructured peer support for patients with remitted bipolar disorder (PARADES): a pragmatic, multicentre, observer-blind, randomised controlled superiority trial. Morriss R., Lobban F., Riste L., Davies L., Holland F., Long R., Lykomitrou G., Peters S., Roberts C., Robinson H., Jones S. 2016
Integrated family and individual therapy for bipolar disorder: results of a treatment development study. Miklowitz DJ., Richards JA., George EL., Frank E., Suddath RL., Powell KB., Sacher JA. 2003
Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy. Rucci P., Frank E., Kostelnik B., Fagiolini A., Mallinger AG., Swartz HA., Thase ME., Siegel L., Wilson D., Kupfer DJ. 2002
A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. Ball JR., Mitchell PB., Corry JC., Skillecorn A., Smith M., Malhi GS. 2006
A web-based preventive intervention program for bipolar disorder: outcome of a 12-months randomized controlled trial. Barnes CW., Hadzi-Pavlovic D., Wilhelm K., Mitchell PB. 2015
Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Bauer MS., McBride L., Williford WO., Glick H., Kinosian B., Altshuler L., Beresford T., Kilbourne AM., Sajatovic M. 2006
Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. Castle D., White C., Chamberlain J., Berk M., Berk L., Lauder S., Murray G., Schweitzer I., Piterman L., Gilbert M. 2010
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Colom F., Vieta E., Martinez-Aran A., Reinares M., Goikolea JM., Benabarre A., Torrent C., Comes M., Corbella B., Parramon G., Corominas J. 2003
Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. Colom F., Vieta E., Reinares M., Martínez-Arán A., Torrent C., Goikolea JM., Gastó C. 2003
Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Colom F., Vieta E., Sánchez-Moreno J., Palomino-Otiniano R., Reinares M., Goikolea JM., Benabarre A., Martínez-Arán A. 2009
Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder. de Barros Pellegrinelli K., de O Costa LF., Silval KI., Dias VV., Roso MC., Bandeira M., Colom F., Moreno RA. 2013
Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. Deckersbach T., Peters AT., Sylvia L., Urdahl A., Magalhães PV., Otto MW., Frank E., Miklowitz DJ., Berk M., Kinrys G., Nierenberg A. 2014
Augmenting psychoeducation with a mobile intervention for bipolar disorder: a randomized controlled trial. Depp CA., Ceglowski J., Wang VC., Yaghouti F., Mausbach BT., Thompson WK., Granholm EL. 2015
A brief dyadic group based psychoeducation program improves relapse rates in recently remitted bipolar disorder: a pilot randomised controlled trial. D'Souza R., Piskulic D., Sundram S. 2010
Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study. Fagiolini A., Frank E., Axelson DA., Birmaher B., Cheng Y., Curet DE., Friedman ES., Gildengers AG., Goldstein T., Grochocinski VJ., Houck PR., Stofko MG., Thase ME., Thompson WK., Turkin SR., Kupfer DJ. 2009
Daily electronic self-monitoring in bipolar disorder using smartphones - the MONARCA I trial: a randomized, placebo-controlled, single-blind, parallel group trial. Faurholt-Jepsen M., Frost M., Ritz C., Christensen EM., Jacoby AS., Mikkelsen RL., Knorr U., Bardram JE., Vinberg M., Kessing LV. 2015
The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Fava GA., Rafanelli C., Tomba E., Guidi J., Grandi S. 2011
Inducing lifestyle regularity in recovering bipolar disorder patients: results from the maintenance therapies in bipolar disorder protocol. Frank E., Hlastala S., Ritenour A., Houck P., Tu XM., Monk TH., Mallinger AG., Kupfer DJ. 1997
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Frank E., Kupfer DJ., Thase ME., Mallinger AG., Swartz HA., Fagiolini AM., Grochocinski V., Houck P., Scott J., Thompson W., Monk T. 2005
The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Frank E., Soreca I., Swartz HA., Fagiolini AM., Mallinger AG., Thase ME., Grochocinski VJ., Houck PR., Kupfer DJ. 2008
Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. Frank E., Swartz HA., Mallinger AG., Thase ME., Weaver EV., Kupfer DJ. 1999
A randomized controlled trial of cognitive behavioral group therapy for bipolar disorder. Gomes BC., Abreu LN., Brietzke E., Caetano SC., Kleinman A., Nery FG., Lafer B. 2011
Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: a 5-year controlled clinical trial. González Isasi A., Echeburúa E., Limiñana JM., González-Pinto A. 2014
Prospective rates of suicide attempts and nonsuicidal self-injury by young people with bipolar disorder participating in a psychotherapy study. Inder ML., Crowe MT., Luty SE., Carter JD., Moor S., Frampton CM., Joyce PR. 2016
How effective is a psychological intervention program for patients with refractory bipolar disorder? A randomized controlled trial. Isasi AG., Echeburúa E., Limiñana JM., González-Pinto A. 2010
The impact of a simple individual psycho-education program on quality of life, rate of relapse and medication adherence in bipolar disorder patients. Javadpour A., Hedayati A., Dehbozorgi GR., Azizi A. 2013
Recovery-focused cognitive-behavioural therapy for recent-onset bipolar disorder: randomised controlled pilot trial. Jones SH., Smith G., Mulligan LD., Lobban F., Law H., Dunn G., Welford M., Kelly J., Mulligan J., Morrison AP. 2015
Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Kessing LV., Hansen HV., Hvenegaard A., Christensen EM., Dam H., Gluud C., Wetterslev J. 2013
Life Goals Collaborative Care for patients with bipolar disorder and cardiovascular disease risk. Kilbourne AM., Goodrich DE., Lai Z., Clogston J., Waxmonsky J., Bauer MS. 2012
Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Kilbourne AM., Post EP., Nossek A., Drill L., Cooley S., Bauer MS. 2008
Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. Lam DH., Hayward P., Watkins ER., Wright K., Sham P. 2005
A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Lam DH., Watkins ER., Hayward P., Bright J., Wright K., Kerr N., Parr-Davis G., Sham P. 2003
Cognitive behaviour therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up. Meyer TD., Hautzinger M. 2012
A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Miklowitz DJ., George EL., Richards JA., Simoneau TL., Suddath RL. 2003
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Miklowitz DJ., Otto MW., Frank E., Reilly-Harrington NA., Kogan JN., Sachs GS., Thase ME., Calabrese JR., Marangell LB., Ostacher MJ., Patel J., Thomas MR., Araga M., Gonzalez JM., Wisniewski SR. 2007
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Miklowitz DJ., Otto MW., Frank E., Reilly-Harrington NA., Wisniewski SR., Kogan JN., Nierenberg AA., Calabrese JR., Marangell LB., Gyulai L., Araga M., Gonzalez JM., Shirley ER., Thase ME., Sachs GS. 2007
Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Miklowitz DJ., Simoneau TL., George EL., Richards JA., Kalbag A., Sachs-Ericsson N., Suddath R. 2000
Family treatment for bipolar disorder: family impairment by treatment interactions. Miller IW., Keitner GI., Ryan CE., Uebelacker LA., Johnson SL., Solomon DA. 2008
Does adjunctive family therapy enhance recovery from bipolar I mood episodes? Miller IW., Solomon DA., Ryan CE., Keitner GI. 2004
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study CME. Parikh SV., Zaretsky A., Beaulieu S., Yatham LN., Young LT., Patelis-Siotis I., Macqueen GM., Levitt A., Arenovich T., Cervantes P., Velyvis V., Kennedy SH., Streiner DL. 2012
A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder. Perich T., Manicavasagar V., Mitchell PB., Ball JR., Hadzi-Pavlovic D. 2013
Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. Perry A., Tarrier N., Morriss R., McCarthy E., Limb K. 1999
Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. Rea MM., Tompson MC., Miklowitz DJ., Goldstein MJ., Hwang S., Mintz J. 2003
A comparison of the life goals program and treatment as usual for individuals with bipolar disorder. Sajatovic M., Davies MA., Ganocy SJ., Bauer MS., Cassidy KA., Hays RW., Safavi R., Blow FC., Calabrese JR. 2009
Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Scott J., Paykel E., Morriss R., Bentall R., Kinderman P., Johnson T., Abbott R., Hayhurst H. 2006
Long-term effectiveness and cost of a systematic care program for bipolar disorder. Simon GE., Ludman EJ., Bauer MS., Unützer J., Operskalski B. 2006
Randomized trial of a population-based care program for people with bipolar disorder. Simon GE., Ludman EJ., Unützer J., Bauer MS., Operskalski B., Rutter C. 2005
Bipolar disorder and family communication: effects of a psychoeducational treatment program. Simoneau TL., Miklowitz DJ., Richards JA., Saleem R., George EL. 1999
Beating Bipolar: exploratory trial of a novel Internet-based psychoeducational treatment for bipolar disorder. Smith DJ., Griffiths E., Poole R., di Florio A., Barnes E., Kelly MJ., Craddock N., Hood K., Simpson S. -- Not Found --
Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy alone. Solomon DA., Keitner GI., Ryan CE., Kelley J., Miller IW. 2008
A web-based self-management intervention for Bipolar Disorder 'living with bipolar': a feasibility randomised controlled trial. Todd NJ., Jones SH., Hart A., Lobban FA. 2014
Collaborative care for patients with bipolar disorder: randomised controlled trial. van der Voort TY., van Meijel B., Goossens PJ., Hoogendoorn AW., Draisma S., Beekman A., Kupka RW. 2015
Collaborative care for patients with bipolar disorder: Effects on functioning and quality of life. van der Voort TY., van Meijel B., Hoogendoorn AW., Goossens PJ., Beekman AT., Kupka RW. 2015
Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. Weiss RD., Griffin ML., Greenfield SF., Najavits LM., Wyner D., Soto JA., Hennen JA. 2000
A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Weiss RD., Griffin ML., Jaffee WB., Bender RE., Graff FS., Gallop RJ., Fitzmaurice GM. 2009
A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Weiss RD., Griffin ML., Kolodziej ME., Greenfield SF., Najavits LM., Daley DC., Doreau HR., Hennen JA. 2007
Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder? Zaretsky A., Lancee W., Miller C., Harris A., Parikh SV. 2008
Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. Harvey AG., Soehner AM., Kaplan KA., Hein K., Lee J., Kanady J., Li D., Rabe-Hesketh S., Ketter TA., Neylan TC., Buysse DJ. 2015
Randomized, controlled trial of Interpersonal and Social Rhythm Therapy for young people with bipolar disorder. Inder ML., Crowe MT., Luty SE., Carter JD., Moor S., Frampton CM., Joyce PR. 2015
Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial. Wenze SJ., Gaudiano BA., Weinstock LM., Tezanos KM., Miller IW. 2015
Patient-reported outcomes in meta-analyses-part 2: methods for improving interpretability for decision-makers. Johnston BC., Patrick DL., Thorlund K., Busse JW., da Costa BR., Schünemann HJ., Guyatt GH. 2013
Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder. Ketter TA., Durgam S., Landbloom R., Mackle M., Wu X., Mathews M. 2017
Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort. Lambert CG., Mazurie AJ., Lauve NR., Hurwitz NG., Young SS., Obenchain RL., Hengartner NW., Perkins DJ., Tohen M., Kerner B. 2016
Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study. Hayes JF., Marston L., Walters K., Geddes JR., King M., Osborn DP. 2016
Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study. Hayes JF., Pitman A., Marston L., Walters K., Geddes JR., King M., Osborn DP. 2016
Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Huang RY., Hsieh KP., Huang WW., Yang YH. 2016
Suicide-related events in patients treated with antiepileptic drugs. Arana A., Wentworth CE., Ayuso-Mateos JL., Arellano FM. 2010
A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder. Bauer MS., Miller CJ., Li M., Bajor LA., Lee A. 2016
Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Gibbons RD., Hur K., Brown CH., Mann JJ. 2009
Evaluation of the safety profile of Zolafren®, a generic olanzapine formulation, in patients with bipolar disorder: a post-authorization safety study. Chudek J., Olszanecka-Glinianowicz M., Almgren-Rachtan A., Gabryelewicz T. 2015
Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Joffe H., Cohen LS., Suppes T., McLaughlin WL., Lavori P., Adams JM., Hwang CH., Hall JE., Sachs GS. 2006
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. Namjoshi MA., Risser R., Shi L., Tohen M., Breier A. 2004
Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison. Altshuler LL., Sugar CA., McElroy SL., Calimlim B., Gitlin M., Keck PE., Aquino-Elias A., Martens BE., Fischer EG., English TL., Roach J., Suppes T. 2017
Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study. Amsterdam JD., Lorenzo-Luaces L., Soeller I., Li SQ., Mao JJ., DeRubeis RJ. 2015
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Amsterdam JD., Shults J. 2010
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial. Arabzadeh S., Ameli N., Zeinoddini A., Rezaei F., Farokhnia M., Mohammadinejad P., Ghaleiha A., Akhondzadeh S. 2015
Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. Bahk WM., Shin YC., Woo JM., Yoon BH., Lee JS., Jon DI., Chung SK., Choi SK., Paik IH., Pae CU. 2005
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Baker RW., Brown E., Akiskal HS., Calabrese JR., Ketter TA., Schuh LM., Trzepacz PT., Watkin JG., Tohen M. 2004
Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Berk M., Ichim L., Brook S. 1999
Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. Berwaerts J., Lane R., Nuamah IF., Lim P., Remmerie B., Hough DW. 2011
A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode. Berwaerts J., Melkote R., Nuamah I., Lim P. 2012
Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study. Berwaerts J., Xu H., Nuamah I., Lim P., Hough D. 2012
A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder. Bobo WV., Epstein RA., Lynch A., Patton TD., Bossaller NA., Shelton RC. -- Not Found --
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Bowden CL., Calabrese JR., McElroy SL., Gyulai L., Wassef A., Petty F., Pope HG., Chou JC., Keck PE., Rhodes LJ., Swann AC., Hirschfeld RM., Wozniak PJ. 2000
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Bowden CL., Calabrese JR., Sachs G., Yatham LN., Asghar SA., Hompland M., Montgomery P., Earl N., Smoot TM., DeVeaugh-Geiss J. 2003
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Bowden CL., Grunze H., Mullen J., Brecher M., Paulsson B., Jones M., Vågerö M., Svensson K. 2005
Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Bowden CL., Mosolov S., Hranov L., Chen E., Habil H., Kongsakon R., Manfredi R., Lin HN. 2010
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. Bowden CL., Swann AC., Calabrese JR., Rubenfaer LM., Wozniak PJ., Collins MA., Abi-Saab W., Saltarelli M. 2006
Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. Bowden CL., Vieta E., Ice KS., Schwartz JH., Wang PP., Versavel M. 2010
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Calabrese JR., Bowden CL., Sachs G., Yatham LN., Behnke K., Mehtonen OP., Montgomery P., Ascher J., Paska W., Earl N., DeVeaugh-Geiss J. 2003
Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study. Calabrese JR., Keck PE., Starace A., Lu K., Ruth A., Laszlovszky I., Németh G., Durgam S. 2015
A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania. Chen J., Lu Z., Zhang M., Zhang J., Ni X., Jiang X., Xu H., Heeramun-Aubeeluck A., Hu Q., Jin H., Davis JM. 2013
Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. Roy Chengappa KN., Schwarzman LK., Hulihan JF., Xiang J., Rosenthal NR. 2006
Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ., Datto C., Nordenhem A., Minkwitz M., Acevedo L., Darko D. 2011
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Durgam S., Starace A., Li D., Migliore R., Ruth A., Németh G., Laszlovszky I. 2015
Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Fan A., Berg A., Bresee C., Glassman LH., Rapaport MH. 2012
Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Greil W., Kleindienst N. 1999
The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Greil W., Kleindienst N. 1999
Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. Greil W., Kleindienst N., Erazo N., Müller-Oerlinghausen B. 1998
Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study. Greil W., Ludwig-Mayerhofer W., Erazo N., Schöchlin C., Schmidt S., Engel RR., Czernik A., Giedke H., Müller-Oerlinghausen B., Osterheider M., Rudolf GA., Sauer H., Tegeler J., Wetterling T. 1997
Maintenance efficacy of divalproex in the prevention of bipolar depression. Gyulai L., Bowden CL., McElroy SL., Calabrese JR., Petty F., Swann AC., Chou JC., Wassef A., Risch CS., Hirschfeld RM., Nemeroff CB., Keck PE., Evans DL., Wozniak PJ. 2003
Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. Hartong EG., Moleman P., Hoogduin CA., Broekman TG., Nolen WA. 2003
Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP., Tohen M., Degenhardt EK., Jamal HH., Liu LL., Ketter TA. 2009
Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ichim L., Berk M., Brook S. 2000
In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder. Jahangard L., Soroush S., Haghighi M., Ghaleiha A., Bajoghli H., Holsboer-Trachsler E., Brand S. 2014
Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial. Jeong HG., Lee MS., Ko YH., Han C., Jung IK. -- Not Found --
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study). Kanba S., Kawasaki H., Ishigooka J., Sakamoto K., Kinoshita T., Kuroki T. 2014
Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study. Katagiri H., Takita Y., Tohen M., Higuchi T., Kanba S., Takahashi M. 2012
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. Keck PE., Calabrese JR., McQuade RD., Carson WH., Carlson BX., Rollin LM., Marcus RN., Sanchez R. 2006
Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. Kemp DE., Gao K., Fein EB., Chan PK., Conroy C., Obral S., Ganocy SJ., Calabrese JR. 2012
Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Khanna S., Vieta E., Lyons B., Grossman F., Eerdekens M., Kramer M. 2005
Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Kleindienst N., Greil W. 2000
Carbamazepine versus lithium in mania: a double-blind study. Lerer B., Moore N., Meyendorff E., Cho SR., Gershon S. 1987
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. Li H., Ma C., Wang G., Zhu X., Peng M., Gu N. 2008
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. Machado-Vieira R., Soares JC., Lara DR., Luckenbaugh DA., Busnello JV., Marca G., Cunha A., Souza DO., Zarate CA., Kapczinski F. 2008
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Marcus R., Khan A., Rollin L., Morris B., Timko K., Carson W., Sanchez R. 2011
Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. McElroy SL., Martens BE., Winstanley EL., Creech R., Malhotra S., Keck PE. 2010
A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. McIntyre RS., Cohen M., Zhao J., Alphs L., Macek TA., Panagides J. 2009
Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial. McIntyre RS., Cohen M., Zhao J., Alphs L., Macek TA., Panagides J. 2010
Lamotrigine in bipolar disorder: efficacy during pregnancy. Newport DJ., Stowe ZN., Viguera AC., Calamaras MR., Juric S., Knight B., Pennell PB., Baldessarini RJ. 2008
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Nierenberg AA., Friedman ES., Bowden CL., Sylvia LG., Thase ME., Ketter T., Ostacher MJ., Leon AC., Reilly-Harrington N., Iosifescu DV., Pencina M., Severe JB., Calabrese JR. 2013
Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. Niufan G., Tohen M., Qiuqing A., Fude Y., Pope E., McElroy H., Ming L., Gaohua W., Xinbao Z., Huichun L., Liang S. 2008
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. Perlis RH., Baker RW., Zarate CA., Brown EB., Schuh LM., Jamal HH., Tohen M. 2006
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. Potkin SG., Keck PE., Segal S., Ice K., English P. 2005
Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Prien RF., Caffey EM., Klett CJ. 1973
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. Revicki DA., Paramore LC., Sommerville KW., Swann AC., Zajecka JM. 2003
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. Sachs G., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Impellizzeri C., Kaplita S., Rollin L., Iwamoto T. 2006
Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial. Sachs GS., Greenberg WM., Starace A., Lu K., Ruth A., Laszlovszky I., Németh G., Durgam S. 2015
Effectiveness of adjunctive antidepressant treatment for bipolar depression. Sachs GS., Nierenberg AA., Calabrese JR., Marangell LB., Wisniewski SR., Gyulai L., Friedman ES., Bowden CL., Fossey MD., Ostacher MJ., Ketter TA., Patel J., Hauser P., Rapport D., Martinez JM., Allen MH., Miklowitz DJ., Otto MW., Dennehy EB., Thase ME. 2007
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. Sachs GS., Vanderburg DG., Karayal ON., Kolluri S., Bachinsky M., Cavus I. 2012
Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Segal J., Berk M., Brook S. -- Not Found --
Olanzapine vs. lithium in management of acute mania. Shafti SS. 2010
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Shi L., Namjoshi MA., Zhang F., Gandhi G., Edgell ET., Tohen M., Breier A., Haro JM. 2002
Carbamazepine compared with lithium in the treatment of mania. Small JG., Klapper MH., Milstein V., Kellams JJ., Miller MJ., Marhenke JD., Small IF. 1991
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Smulevich AB., Khanna S., Eerdekens M., Karcher K., Kramer M., Grossman F. 2005
Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension. Szegedi A., Calabrese JR., Stet L., Mackle M., Zhao J., Panagides J. 2012
Olanzapine versus divalproex in the treatment of acute mania. Tohen M., Baker RW., Altshuler LL., Zarate CA., Suppes T., Ketter TA., Milton DR., Risser R., Gilmore JA., Breier A., Tollefson GA. 2002
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Tohen M., Calabrese JR., Sachs GS., Banov MD., Detke HC., Risser R., Baker RW., Chou JC., Bowden CL. 2006
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Tohen M., Chengappa KN., Suppes T., Zarate CA., Calabrese JR., Bowden CL., Sachs GS., Kupfer DJ., Baker RW., Risser RC., Keeter EL., Feldman PD., Tollefson GD., Breier A. 2002
A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Tohen M., Goldberg JF., Gonzalez-Pinto Arrillaga AM., Azorin JM., Vieta E., Hardy-Bayle MC., Lawson WB., Emsley RA., Zhang F., Baker RW., Risser RC., Namjoshi MA., Evans AR., Breier A. 2003
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Tohen M., Jacobs TG., Grundy SL., McElroy SL., Banov MC., Janicak PG., Sanger T., Risser R., Zhang F., Toma V., Francis J., Tollefson GD., Breier A. 2000
Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Vasudev K., Goswami U., Kohli K. 2000
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Vieta E., Bourin M., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Swanink R., Iwamoto T. 2005
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Vieta E., Cruz N., García-Campayo J., de Arce R., Manuel Crespo J., Vallès V., Pérez-Blanco J., Roca E., Manuel Olivares J., Moríñigo A., Fernández-Villamor R., Comes M. 2008
A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. Vieta E., Manuel Goikolea J., Martínez-Arán A., Comes M., Verger K., Masramon X., Sanchez-Moreno J., Colom F. 2006
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder. Vieta E., Montgomery S., Sulaiman AH., Cordoba R., Huberlant B., Martinez L., Schreiner A. 2012
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E., Owen R., Baudelet C., McQuade RD., Sanchez R., Marcus RN. 2010
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). Vieta E., Suppes T., Eggens I., Persson I., Paulsson B., Brecher M. 2008
Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Vieta E., T'joen C., McQuade RD., Carson WH., Marcus RN., Sanchez R., Owen R., Nameche L. 2008
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Weiser M., Burshtein S., Gershon AA., Marian G., Vlad N., Grecu IG., Tocari E., Tiugan A., Hotineanu M., Davis JM. 2014
Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). Weisler RH., Nolen WA., Neijber A., Hellqvist A., Paulsson B. 2011
Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. Woo YS., Bahk WM., Chung MY., Kim DH., Yoon BH., Lee JH., Ahn YM., Chung SK., Kim JG., Lee KH., Paik KC. 2011
Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group. Xu L., Lu Y., Yang Y., Zheng Y., Chen F., Lin Z. 2015
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Yatham LN., Grossman F., Augustyns I., Vieta E., Ravindran A. 2003
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Yatham LN., Vieta E., Young AH., Möller HJ., Paulsson B., Vågerö M. 2007
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Yildiz A., Guleryuz S., Ankerst DP., Ongür D., Renshaw PF. 2008
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Young AH., Oren DA., Lowy A., McQuade RD., Marcus RN., Carson WH., Spiller NH., Torbeyns AF., Sanchez R. 2009
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Zarate CA., Tohen M. 2004
Adjunctive treatment with gabapentin in bipolar patients during acute mania. Astaneh AN., Rezaei O. 2012
Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. Lee SY., Chen SL., Chang YH., Chen PS., Huang SY., Tzeng NS., Wang YS., Wang LJ., Lee IH., Yeh TL., Yang YK., Lu RB., Hong JS. 2013
Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial. Conus P., Berk M., Cotton SM., Kader L., Macneil C., Hasty MK., Hallam K., Lambert M., Murphy BP., McGorry PD. 2015
Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder. Landbloom RL., Mackle M., Wu X., Kelly L., Snow-Adami L., McIntyre RS., Mathews M., Hundt C. 2016
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. Nierenberg AA., McElroy SL., Friedman ES., Ketter TA., Shelton RC., Deckersbach T., McInnis MG., Bowden CL., Tohen M., Kocsis JH., Calabrese JR., Kinrys G., Bobo WV., Singh V., Kamali M., Kemp D., Brody B., Reilly-Harrington NA., Sylvia LG., Shesler LW., Bernstein EE., Schoenfeld D., Rabideau DJ., Leon AC., Faraone S., Thase ME. 2016
Endoxifen, a New Treatment Option for Mania: A Double-Blind, Active-Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen. Ahmad A., Sheikh S., Shah T., Reddy MS., Prasad B., Verma KK., Chandrakant BB., Paithankar M., Kale P., Solanki RV., Patel R., Barkate H., Ahmad I. 2016
Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate. Amsterdam JD., Lorenzo-Luaces L., Soeller I., Li SQ., Mao JJ., DeRubeis RJ. 2016
Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk. Lorenzo-Luaces L., Amsterdam JD., Soeller I., DeRubeis RJ. 2016
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study. Calabrese JR., Sanchez R., Jin N., Amatniek J., Cox K., Johnson B., Perry P., Hertel P., Such P., Salzman PM., McQuade RD., Nyilas M., Carson WH. 2017
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. Tohen M., Vieta E., Goodwin GM., Sun B., Amsterdam JD., Banov M., Shekhar A., Aaronson ST., Bardenstein L., Grecu-Gabos I., Tochilov V., Prelipceanu D., Oliff HS., Kryzhanovskaya L., Bowden C. 2008
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Amsterdam JD., Wang CH., Shwarz M., Shults J. 2009
Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications. Bowden CL., Karayal ON., Schwartz JH., Gundapaneni BK., O'Gorman C. 2013
Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. Yatham LN., Paulsson B., Mullen J., Vågerö AM. 2004
Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Quiroz JA., Yatham LN., Palumbo JM., Karcher K., Kushner S., Kusumakar V. 2010
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Tohen M., Bowden CL., Smulevich AB., Bergstrom R., Quinlan T., Osuntokun O., Wang WV., Oliff HS., Martenyi F., Kryzhanovskaya LA., Greil W. 2008
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Amsterdam JD., Shults J. 2008
A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder. Vieta E., Nuamah IF., Lim P., Yuen EC., Palumbo JM., Hough DW., Berwaerts J. 2010
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Macfadden W., Alphs L., Haskins JT., Turner N., Turkoz I., Bossie C., Kujawa M., Mahmoud R. 2009
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Suppes T., Vieta E., Liu S., Brecher M., Paulsson B. 2009
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Keck PE., Versiani M., Potkin S., West SA., Giller E., Ice K. 2003
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Tohen M., Greil W., Calabrese JR., Sachs GS., Yatham LN., Oerlinghausen BM., Koukopoulos A., Cassano GB., Grunze H., Licht RW., Dell'Osso L., Evans AR., Risser R., Baker RW., Crane H., Dossenbach MR., Bowden CL. 2005
Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. McIntyre RS., Brecher M., Paulsson B., Huizar K., Mullen J. 2005
Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Kushner SF., Khan A., Lane R., Olson WH. 2006
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. Zajecka JM., Weisler R., Sachs G., Swann AC., Wozniak P., Sommerville KW. 2002
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Geddes JR., Goodwin GM., Rendell J., Azorin JM., Cipriani A., Ostacher MJ., Morriss R., Alder N., Juszczak E. 2010
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. Weisler RH., Hirschfeld R., Cutler AJ., Gazda T., Ketter TA., Keck PE., Swann A., Kalali A. 2006
Genotype variant associated with add-on memantine in bipolar II disorder. Lee SY., Chen SL., Chang YH., Chen SH., Chu CH., Huang SY., Tzeng NS., Wang CL., Wang LJ., Lee IH., Yeh TL., Yang YK., Hong JS., Lu RB. 2014
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Carlson BX., Ketter TA., Sun W., Timko K., McQuade RD., Sanchez R., Vester-Blokland E., Marcus R. 2012
Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Nierenberg AA., Sylvia LG., Leon AC., Reilly-Harrington NA., Shesler LW., McElroy SL., Friedman ES., Thase ME., Shelton RC., Bowden CL., Tohen M., Singh V., Deckersbach T., Ketter TA., Kocsis JH., McInnis MG., Schoenfeld D., Bobo WV., Calabrese JR. 2014




Creative Commons LicenseThis graphic notice indicates that you are leaving this Federal Government Web site and entering a non-Federal Web site. Creative Commons  
The data contained in this project are distributed under the terms of the Creative Commons Attribution-NonCommerical license, which permits the use, dissemination, and reproduction in any medium, provided the original work is properly cited, and that the use is non-commercial and otherwise in compliance with the license. See: https://creativecommons.org/licenses/by-nc/3.0/